Alignment Healthcare Inc
ALHCHealthcare·Healthcare Plans·USA·Small·NASD·Nov 13 • 7:01 AM ET
7.45-0.05 (-0.67%)
2026-11-13 13:48 CET
Market cap
$1.56B
Revenue, TTM
4,941.92 USD m
Net income, TTM
28.92 USD m
Free cash flow, TTM
77.04 USD m
EPS diluted, TTM
0.13
57.22
Price
ALHC against its 20, 50 and 200-day averagesPatternshover a marker to name it
70.3% under the 52-week high of 25.12 on 7 Jul 2026. 52-week low 6.01 on 9 Oct 2026. Last 15 sessions, 23.9% high to low
Volume 0.01× normal · the line is the 50-bar volume average
Setup. RS line 0
CANSLIM 2 of 6 — fails: EPS Growth Qtr Over Qtr: High (>25%); 52-Week High/Low: 0-10% below High; Performance: Year +50% — not on the tape: EPS Growth This Year: High (>25%)
VCP 3 of 6 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High
Minervini 0 of 4 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High; Performance: Year +50%
Zanger 0 of 5 — fails: RSI (14): Not Oversold (>50); Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5; 200-Day Simple Moving Average: Price above SMA200
Leaders 1 of 5 — fails: 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%; 52-Week High/Low: 0-10% below High
Breakout 0 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2; 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200
Growth 1 of 4 — fails: EPS Growth Qtr Over Qtr: High (>25%); Return on Equity: Over +15% — not on the tape: EPS Growth This Year: High (>25%)
Quality 1 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%); Debt/Equity: Low (<0.1); P/E: Under 25
Value 0 of 4 — fails: P/E: Under 15; P/B: Under 2; Return on Equity: Over +15%; Debt/Equity: Low (<0.1)
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years; P/E: Under 25 — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%)
Small Cap 1 of 4 — fails: Float: Under 100M; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%
Accumulation 1 of 4 — fails: Institutional Transactions: Over +10%; 200-Day Simple Moving Average: Price above SMA200; Performance: Year Up
Relative Strength 1 of 3 — fails: Performance: Year +100%; 200-Day Simple Moving Average: Price above SMA200
Profile
ALHC52-week range, 8% of the way up
6.0125.12
Alignment Healthcare, Inc. is a holding company, which offers a consumer-centric platform that delivers customized health care solutions to seniors and those who need it most, the chronically ill and frail, through its Medicare Advantage plans. It offers health plan options through Alignment Health Plan, and partners with select health plans to help deliver better benefits at lower costs. The company was founded by John E. Kao in 2013 and is headquartered in Orange, CA.
| Index | RUT |
|---|---|
| Employees | 1849 |
| IPO | Mar 26, 2021 |
| Beta | 1.04 |
| ATR, 14d | 0.52 |
| Rel volume | 0.01 |
| Short float | 11.57% |
| Insider own | 4.36% |
| Inst own | 110.12% |
Snapshot
6 groupsValuation
| Index | RUT |
|---|---|
| Market Cap | $1.56B |
| Enterprise Value | - |
| Income | 28.92M |
| Sales | 4.94B |
| Book / share | 1.32 |
| Cash / share | - |
| Dividend Est. | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Dividend Gr. 3/5Y | - - |
| Payout | - |
| Employees | 1849 |
| IPO | Mar 26, 2021 |
Ratios
| Price / earnings | 57.22 |
|---|---|
| Forward price / earnings | 45.80 |
| Price / earnings / growth | - |
| Price / sales | 0.32 |
| Price / book | 5.62 |
| Price / cash | - |
| Price / free cash flow | 20.24 |
| Value / cash profit | - |
| Value / sales | - |
| Quick Ratio | - |
| Current Ratio | 1.71 |
| Debt / equity | 1.19 |
| Long-term debt / equity | 1.19 |
| Options and short | Yes / Yes |
Earnings
| Earnings / share | 0.13 |
|---|---|
| Earnings next year | 0.16 |
| Earnings next quarter | -0.22 |
| Earnings this year | - |
| Earnings next year | 616.66% |
| Earnings growth, 5 years | - |
| Past earnings growth | 83.51% 50.33% |
| Past sales growth | 40.16% 32.71% |
| Earnings vs last year | 224.33% |
| Sales vs last year | 35.87% |
| Earnings vs last quarter | -316.85% |
| Sales vs last quarter | 36.69% |
| Earnings | Oct 29 AMC |
| Surprise | -9.89% 3.51% |
Ownership
| Insiders own | 4.36% |
|---|---|
| Insider trades | -20.30% |
| Institutions own | 110.12% |
| Institution trades | 7.32% |
| Return on assets | 2.41% |
| Return on equity | 13.17% |
| Return on capital | 4.76% |
| Gross Margin | - |
| Operating margin | 0.88% |
| Profit Margin | 0.59% |
| 20-day average | -4.67% |
| 50-day average | -14.02% |
| 200-day average | -53.56% |
Technical
| Shares out | 209.15M |
|---|---|
| Shares floating | 200.14M |
| Short / float | 11.57% |
| Short ratio | 2.89 |
| Short interest | 23.15M |
| 52-week high | 25.12 -70.3% |
| 52-week low | 6.01 +24.0% |
| Volatility | 5.17% 6.04% |
| Average range | 0.52 |
| Strength index | 41.77 |
| Market sensitivity | 1.04 |
| Relative volume | 0.01 |
| Avg Volume | 8.02M |
| Volume | 2,721 |
Performance
| Perf Week | 1.50% |
|---|---|
| Perf Month | -8.59% |
| Perf Quarter | -44.65% |
| Perf Half Y | -52.64% |
| Perf YTD | -62.28% |
| Perf Year | -55.58% |
| Perf 3Y | 22.73% |
| Perf 5Y | -65.56% |
| Perf 10Y | - |
| Recommendation | 1.94 |
| Target Price | 10.79 |
| Prev Close | 7.50 |
| Price | 7.45 |
| Change % | -0.67% |
Analyst ratings
latest 10 of 20| Date | Action | Analyst | Rating change | Target | Implied |
|---|---|---|---|---|---|
| Oct 30, 2026 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight | ||
| Oct 28, 2026 | Initiated | Needham | Hold | ||
| Oct 09, 2026 | Downgrade | William Blair | Outperform → Mkt Perform | ||
| Aug 03, 2026 | Downgrade | Raymond James | Strong Buy → Outperform | $19 | +155.0% |
| Apr 17, 2026 | Initiated | Wolfe Research | Outperform | $24 | +222.1% |
| Nov 24, 2025 | Upgrade | JP Morgan | Neutral → Overweight | $20 | +168.5% |
| Oct 14, 2025 | Initiated | Goldman | Buy | $21 | +181.9% |
| Aug 25, 2025 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight | $21 | +181.9% |
| Jul 31, 2025 | Upgrade | Barclays | Underweight → Equal Weight | $13 | +74.5% |
| Dec 03, 2024 | Upgrade | Stephens | Equal-Weight → Overweight | $13 → $17 | +128.2% |
Peers
Mkt capInsider trading
latest 14 of 100| Insider | Relationship | Date | Transaction | Cost | Shares | Value | Total held | Form |
|---|---|---|---|---|---|---|---|---|
| KONOWIECKI JOSEPH S | EVP, Corporate Affairs | Nov 10 '26 | Sale | 7.20 | 4,930 | 35,496 | 1,075,375 | Nov 12 05:57 PM |
| Joseph Konowiecki | Chairman / EVP, Corporate Affa | Nov 10 '26 | Proposed Sale | 7.27 | 5,500 | 39,985 | Nov 09 05:57 PM | |
| Kim Hyong | Chief Medical Officer | Oct 06 '26 | Sale | 8.30 | 32,479 | 269,576 | 299,271 | Oct 07 04:00 PM |
| Hyong (Ken) Kim, M.D. | Chief Medical Officer | Oct 06 '26 | Proposed Sale | 8.48 | 36,000 | 305,280 | Oct 05 05:14 PM | |
| KONOWIECKI JOSEPH S | EVP, Corporate Affairs | Sep 17 '26 | Sale | 8.61 | 23,511 | 202,430 | 1,080,305 | Sep 18 04:29 PM |
| KAO JOHN E | Chief Executive Officer | Sep 14 '26 | Sale | 13.00 | 27,400 | 356,200 | 590,766 | Sep 16 05:57 PM |
| Joseph Konowiecki | Director / EVP, Corporate Affa | Sep 17 '26 | Proposed Sale | 8.71 | 26,000 | 226,460 | Sep 16 05:52 PM | |
| Maroney Dawn Christine | President | Sep 11 '26 | Sale | 12.68 | 122,707 | 1,555,925 | 794,606 | Sep 11 08:41 PM |
| KAO JOHN E | Chief Executive Officer | Sep 11 '26 | Sale | 12.68 | 385,270 | 4,885,224 | 1,223,473 | Sep 11 08:38 PM |
| KAO JOHN E | Chief Executive Officer | Sep 10 '26 | Sale | 12.96 | 172,600 | 2,236,447 | 618,166 | Sep 11 08:38 PM |
| JEK TRUST U/A DTD 02/08/2021 | Director | Sep 10 '26 | Proposed Sale | 13.03 | 500,000 | 6,515,000 | Sep 10 04:37 PM | |
| Dawn C. Maroney | President | Sep 10 '26 | Proposed Sale | 13.06 | 130,000 | 1,697,800 | Sep 09 06:00 PM | |
| John Kao | Chief Executive Officer / Dire | Sep 10 '26 | Proposed Sale | 13.06 | 405,000 | 5,289,300 | Sep 09 05:57 PM | |
| Maroney Dawn Christine | President | Aug 14 '26 | Sale | 14.00 | 5,000 | 70,000 | 917,313 | Aug 18 04:01 PM |
Held by
AUM| Ticker | Company | AUM |
|---|---|---|
| IJR | iShares Core S&P Small-Cap ETF | AUM: 107.13B |
| VTI | Vanguard Morningstar Total Stock Market ETF | AUM: 696.31B |
| IWM | iShares Russell 2000 Index Fund | AUM: 77.86B |
| VB | Vanguard Morningstar Small-Cap ETF | AUM: 80.23B |
| VBK | Vanguard Morningstar Small-Cap Growth ETF | AUM: 22.68B |
| VXF | Vanguard Extended Market Index ETF | AUM: 30.79B |
| IWO | iShares Russell 2000 Growth ETF | AUM: 14.25B |
| SPSM | State Street SPDR Portfolio S&P 600TM Small Cap ETF | AUM: 16.19B |
| IJT | iShares S&P Small-Cap 600 Growth ETF | AUM: 7.52B |
| DFAS | U.S. Small Cap Portfolio-ETF Class Shares | AUM: 15.64B |
News
latest 14 of 200- Survey Suggests a Simple Beverage Swap Can Inspire Healthier Habits Among Seniors (GlobeNewswire) +5.50%
- Alignment Healthcare (NASDAQ: ALHC) Increasingly Scrutinized Over H3815 Cut Points And CMS Bonus Eligibility - HBSS (PR Newswire) -9.80%
- Alignment Healthcare Matches EPS Forecast, But A Medical-Cost Surge Forces A Steep Profit Reset Despite Accelerating Growth (Earnings Whispers)
- Alignment Healthcare: Q3 Earnings Snapshot (Associated Press)
- Alignment Healthcare Reports Third Quarter 2026 Results, Updates Full-Year Outlook (GlobeNewswire)
- Alignment Health Adds New Medicare Advantage Plan in Pima County, Increasing Access and Choice for Arizona Seniors (GlobeNewswire)
- Alignment Healthcare's Planned Third-Quarter Dip Meets A Stock That Has Lost Nearly Half Its Value (Earnings Whispers)
- Alignment Health Expands Medicare Advantage Plan to Nye County for 2027 (GlobeNewswire)
- Alignment Health Plan Recognized Among U.S. News & World Report's 2027 Best Insurance Companies for Medicare Advantage (GlobeNewswire)
- Alignment Health Plan and Astrana Health Partner to Expand Access to Trusted Local Care for California Seniors (GlobeNewswire)
- Alignment Health Expands Medicare Advantage Coverage to San Antonio for 2027 (GlobeNewswire)
- Alignment Healthcare to Announce Third Quarter 2026 Financial Results and Host Conference Call Thursday, Oct. 29, 2026 (GlobeNewswire)
- ALHC: Alignment Healthcare Investors Should Contact Block & Leviton to Possibly Recover Losses (Newsfile)
- Alignment sues CMS over 2027 Medicare Advantage star ratings crash (Healthcare Dive)
Quarterly earnings
2026Q3 EPS -0.040 missed -0.036, from 0.020 a year earlier. Sales 1,358 beat 1,312, from 993.7 a year earlier
The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.
| Period | Reported | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | Surprise | Year-ago quarter | Analysts | Next session |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026Q3ended 2026-09-30 | 2026-10-29 16:30 | -0.040 | -0.036 | -0.040 | 1,358 | 1,312 | EPS +9.9% · sales +3.5% | vs 2025Q3, year-ago quarter · EPS -300.0% · sales +36.7% | 12 | Open -1.24% vs SPY -1.04%. Close -9.80% vs SPY -1.77% |
| 2026Q2ended 2026-06-30 | 2026-07-30 16:30 | 0.170 | 0.129 | 0.170 | 1,336 | 1,310 | EPS +31.8% · sales +2.0% | vs 2025Q2, year-ago quarter · EPS +142.9% · sales +31.6% | 11 | Open -16.71% vs SPY +0.40%. Close -20.20% vs SPY +0.72% |
| 2026Q1ended 2026-03-31 | 2026-04-30 16:30 | 0.050 | 0.007 | 0.054 | 1,235 | 1,218 | EPS +604.2% · sales +1.4% | vs 2025Q1, year-ago quarter · EPS -200.0% · sales +33.3% | 11 EPS · 12 sales | Open -6.30% vs SPY +0.36%. Close -10.12% vs SPY +0.28% |
| 2025Q4ended 2025-12-31 | 2026-02-26 16:30 | -0.050 | -0.154 | -0.055 | 1,013 | 1,003 | EPS -67.5% · sales +0.9% | vs 2024Q4, year-ago quarter · EPS -68.8% · sales +44.4% | 10 EPS · 11 sales | Open -7.74% vs SPY -0.90%. Close -5.88% vs SPY -0.48% |
| 2025Q3ended 2025-09-30 | 2025-10-30 16:30 | 0.020 | -0.081 | 0.018 | 993.7 | 981.34 | EPS -124.6% · sales +1.3% | vs 2024Q3, year-ago quarter · EPS -114.3% · sales +43.5% | 10 EPS · 11 sales | Open +8.24% vs SPY +0.77%. Close -1.52% vs SPY +0.33% |
| 2025Q2ended 2025-06-30 | 2025-07-30 16:30 | 0.070 | -0.072 | 0.075 | 1,015 | 960.51 | EPS -197.6% · sales +5.7% | vs 2024Q2, year-ago quarter · EPS -153.8% · sales +49.0% | 9 EPS · 10 sales | Open +15.38% vs SPY +0.79%. Close +6.00% vs SPY -0.38% |
| 2025Q1ended 2025-03-31 | 2025-05-01 16:30 | -0.050 | -0.127 | -0.047 | 926.93 | 888.23 | EPS -60.5% · sales +4.4% | vs 2024Q1, year-ago quarter · EPS -80.0% · sales +47.5% | 8 EPS · 10 sales | Open +1.67% vs SPY +1.12%. Close -7.39% vs SPY +1.48% |
| 2024Q4ended 2024-12-31 | 2025-02-27 16:30 | -0.160 | -0.186 | -0.162 | 701.24 | 676.79 | EPS -13.8% · sales +3.6% | vs 2023Q4, year-ago quarter · EPS -36.0% · sales +50.7% | 9 EPS · 11 sales | Open +11.80% vs SPY +0.09%. Close +16.48% vs SPY +1.56% |
| 2024Q3ended 2024-09-30 | 2024-10-29 16:30 | -0.140 | -0.110 | -0.138 | 692.43 | 669.79 | EPS +27.2% · sales +3.4% | vs 2023Q3, year-ago quarter · EPS -26.3% · sales +51.6% | 12 EPS · 11 sales | Open 0.00% vs SPY -0.08%. Close +0.17% vs SPY -0.30% |
| 2024Q2ended 2024-06-30 | 2024-08-01 16:30 | -0.130 | -0.143 | -0.126 | 681.29 | 637.66 | EPS -8.9% · sales +6.8% | vs 2023Q2, year-ago quarter · EPS -13.3% · sales +47.3% | 8 EPS · 10 sales | Open +3.83% vs SPY -1.34%. Close +3.71% vs SPY -1.86% |
| 2024Q1ended 2024-03-31 | 2024-05-02 16:30 | -0.250 | -0.228 | -0.246 | 628.6 | 599.75 | EPS +9.9% · sales +4.8% | vs 2023Q1, year-ago quarter · EPS +25.0% · sales +43.1% | 9 EPS · 10 sales | Open +8.75% vs SPY +1.21%. Close +26.05% vs SPY +1.24% |
| 2023Q4ended 2023-12-31 | 2024-02-27 16:30 | -0.250 | -0.227 | -0.251 | 465.39 | 444.56 | EPS +10.3% · sales +4.7% | vs 2022Q4, year-ago quarter · EPS -19.4% · sales +28.6% | 8 EPS · 10 sales | Open -5.35% vs SPY -0.32%. Close -18.21% vs SPY -0.13% |
| 2023Q3ended 2023-09-30 | 2023-11-02 16:30 | -0.190 | -0.184 | -0.187 | 456.71 | 443.45 | EPS +3.5% · sales +3.0% | vs 2022Q3, year-ago quarter · EPS -13.6% · sales +26.7% | 8 EPS · 9 sales | - |
| 2023Q2ended 2023-06-30 | 2023-08-03 16:30 | -0.150 | -0.183 | -0.153 | 462.38 | 438.97 | EPS -18.0% · sales +5.3% | vs 2022Q2, year-ago quarter · EPS +150.0% · sales +26.2% | 10 EPS · 8 sales | - |
| 2023Q1ended 2023-03-31 | 2023-05-04 16:30 | -0.200 | -0.255 | -0.204 | 439.16 | 431.34 | EPS -21.7% · sales +1.8% | vs 2022Q1, year-ago quarter · EPS -13.0% · sales +27.1% | 7 EPS · 8 sales | - |
| 2022Q4ended 2022-12-31 | 2023-02-28 16:30 | -0.310 | -0.297 | -0.312 | 361.81 | 341.1 | EPS +4.4% · sales +6.1% | vs 2021Q4, year-ago quarter · EPS +14.8% · sales +21.3% | 7 EPS · 8 sales | - |
Annual earnings
2025FY EPS 0.000 beat -0.102, from -0.670 a year earlier. Sales 3,949 beat 3,939, from 2,704 a year earlier
Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.
earnings feed, not the snapshot. Not the statement ratio.
| Period | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | P/E, earnings feed |
|---|---|---|---|---|---|---|
| 2030FYestimate | - | 1.300 | - | - | 12,210 | 5.73 |
| 2029FYestimate | - | 0.815 | - | - | 10,051 | 9.14 |
| 2028FYestimate | - | 0.124 | - | - | 7,720 | 60.13 |
| 2027FYestimate | - | 0.163 | - | - | 6,574 | 45.79 |
| 2026FYestimate | - | -0.032 | - | - | 5,260 | - |
| 2025FY | 0.000 | -0.102 | 0.000 | 3,949 | 3,939 | - |
| 2024FY | -0.670 | -0.683 | -0.671 | 2,704 | 2,679 | - |
| 2023FY | -0.790 | -0.656 | -0.795 | 1,824 | 1,802 | - |
| 2022FY | -0.830 | -0.796 | -0.825 | 1,434 | 1,413 | - |
| 2021FY | -1.140 | -1.003 | -1.136 | 1,168 | 1,140 | - |
| 2020FY | -0.135 | - | -0.122 | 959.29 | - | - |
Quarterly results
2026Q3 revenue 1,358, from 993.7 a year earlier
From the quarterly statement. Not an estimate.
Estimate revisions
Latest snapshot of each period and type. 2026FY E -0.03 per share.
| Period | Type | Scale | Date | Mean | vs prior date |
|---|---|---|---|---|---|
| 2026FY | E | per share | 2026-11-03 | -0.03 | +0.6% |
| 2026Q4 | E | per share | 2026-11-03 | -0.22 | -0.2% |
| 2026FY | R | per share | 2026-11-03 | -0.03 | +0.6% |
| 2026Q4 | R | per share | 2026-11-03 | -0.22 | -0.2% |
| 2026FY | S | USD millions | 2026-10-30 | 5,260 | +0.8% |
| 2026Q4 | S | USD millions | 2026-10-30 | 1,334 | +0.1% |
| 2026Q3 | E | per share | 2026-10-27 | -0.04 | -6.4% |
| 2026Q3 | R | per share | 2026-10-27 | -0.04 | -6.4% |
| 2026Q3 | S | USD millions | 2026-10-27 | 1,312 | 0.0% |
| 2026Q2 | S | USD millions | 2026-07-26 | 1,310 | +0.2% |
| 2026Q2 | E | per share | 2026-07-20 | 0.13 | 0.0% |
| 2026Q2 | R | per share | 2026-07-20 | 0.13 | 0.0% |
| 2026Q1 | E | per share | 2026-04-16 | 0.01 | +4.4% |
| 2026Q1 | R | per share | 2026-04-16 | 0.01 | +4.4% |
| 2026Q1 | S | USD millions | 2026-04-16 | 1,218 | 0.0% |
| 2025FY | S | USD millions | 2026-02-25 | 3,939 | 0.0% |
| 2025Q4 | S | USD millions | 2026-02-25 | 1,003 | +0.0% |
| 2025FY | E | per share | 2026-02-04 | -0.10 | -0.1% |
| 2025Q4 | E | per share | 2026-02-04 | -0.15 | -0.1% |
| 2025FY | R | per share | 2026-02-04 | -0.10 | -0.1% |
| 2025Q4 | R | per share | 2026-02-04 | -0.15 | -0.1% |
| 2025Q3 | S | - | 2025-10-27 | 981.33 | 0.0% |
| 2025Q3 | E | per share | 2025-10-19 | -0.08 | 0.0% |
| 2025Q3 | R | per share | 2025-10-19 | -0.08 | 0.0% |
| 2025Q2 | E | per share | 2025-07-28 | -0.07 | 0.0% |
| 2025Q2 | R | per share | 2025-07-28 | -0.07 | 0.0% |
| 2025Q2 | S | - | 2025-07-28 | 960.51 | 0.0% |
| 2025Q1 | E | per share | 2025-04-21 | -0.13 | -2.0% |
| 2025Q1 | R | per share | 2025-04-21 | -0.13 | -2.0% |
| 2025Q1 | S | - | 2025-04-21 | 888.26 | 0.0% |
| 2024FY | E | per share | 2025-02-20 | -0.68 | +5.7% |
| 2024Q4 | E | per share | 2025-02-20 | -0.19 | +4.4% |
| 2024FY | R | per share | 2025-02-20 | -0.68 | -0.3% |
| 2024Q4 | R | per share | 2025-02-20 | -0.18 | -1.2% |
| 2024FY | S | USD millions | 2025-02-20 | 2,679 | +0.1% |
| 2024Q4 | S | - | 2025-02-20 | 676.79 | +0.2% |
| 2024Q3 | S | - | 2024-10-27 | 662.11 | 0.0% |
| 2024Q3 | E | per share | 2024-10-21 | -0.14 | -0.6% |
| 2024Q3 | R | per share | 2024-10-16 | -0.14 | 0.0% |
| 2024Q2 | S | - | 2024-07-29 | 637.66 | +0.0% |
| 2024Q2 | E | per share | 2024-07-21 | -0.14 | 0.0% |
| 2024Q2 | R | per share | 2024-07-17 | -0.14 | 0.0% |
| 2024Q1 | E | per share | 2024-04-30 | -0.23 | +0.5% |
| 2024Q1 | R | per share | 2024-04-30 | -0.23 | +0.7% |
| 2024Q1 | S | - | 2024-04-30 | 599.75 | +0.4% |
| 2023FY | R | per share | 2024-02-21 | -0.75 | +0.2% |
| 2023FY | S | USD millions | 2024-02-20 | 1,802 | +0.1% |
| 2023FY | E | per share | 2024-01-19 | -0.76 | +0.1% |
Estimate history
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | MRQ |
|---|---|---|---|---|---|---|---|---|---|
| EPS per share | -0.239 | -0.122 | -1.136 | -0.825 | -0.795 | -0.671 | -0.004 | 0.1302 | - |
| Sales USD millions | 757 | 959 | 1,168 | 1,434 | 1,824 | 2,704 | 3,949 | 4,942 | - |
| Shares million shares | 187 | 187 | 187 | 187 | 189 | 192 | 204 | - | 209 |
| Metric | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|
| EPS per share | -0.138 | -0.162 | -0.047 | 0.075 | 0.018 | -0.055 | 0.054 | 0.17 | -0.039 |
| Sales USD millions | 692 | 701 | 927 | 1,015 | 994 | 1,013 | 1,235 | 1,336 | 1,358 |
| Shares million shares | 192 | 192 | 198 | 198 | 200 | 204 | 207 | 207 | 209 |
Income statement, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 4,941.92 | 3,948.72+46.1% | 2,703.56+48.3% | 1,823.63+27.2% | 1,434.16+22.8% | 1,167.77+21.7% | 959.22+26.7% | 756.96 |
| Losses, Claims & Reserves | 4,352.49 | 3,460.16+43.8% | 2,406.87+48.3% | 1,622.60+29.8% | 1,249.88+20.3% | 1,039.04+31.0% | 792.99+19.9% | 661.39 |
| Selling, General and Administrative Incl. Other | 545.91 | 473.81+19.0% | 398.25+21.1% | 328.85+5.1% | 312.92+2.0% | 306.80+78.9% | 171.49+37.1% | 125.06 |
| Operating Income before Interest Expense | 43.52 | 14.75 | -101.56 | -127.82 | -128.64 | -178.07 | -5.26 | -29.48 |
| Interest Expense | 16.57 | 15.80-32.9% | 23.55+10.9% | 21.23+16.1% | 18.29+4.9% | 17.44+3.0% | 16.93+13.6% | 14.90 |
| Unusual Expense | - | 0.00-100.0% | 3.02 | 0.00-100.0% | 2.20 | - | - | - |
| Net Income Before Taxes | 26.96 | -0.96 | -128.05 | -148.19 | -149.30 | -195.29 | -22.93 | -44.73 |
| Income Taxes | -1.96 | 0.020.0% | 0.02 | -0.02-105.9% | 0.34 | 0.00 | 0.00 | 0.00 |
| Consolidated Net Income | 28.92 | -0.98 | -128.07 | -148.17 | -149.64 | -195.29 | -22.93 | -44.73 |
| Net Income From Continuing Operations | 28.92 | -0.72 | -128.03 | -148.02 | -149.55 | -195.29 | -22.93 | -44.73 |
| Net Income | 28.92 | -0.72 | -128.03 | -148.02 | -149.55 | -195.29 | -22.93 | -44.73 |
| EPS (Recurring) per share | 0.14 | -0.00 | -0.66 | -0.79 | -0.82 | -1.14 | -0.12 | -0.24 |
| EPS (Basic, Before Extraordinaries) per share | 0.14 | -0.00 | -0.67 | -0.79 | -0.83 | -1.14 | -0.12 | -0.24 |
| EPS (Diluted) per share | 0.13 | -0.00 | -0.67 | -0.79 | -0.83 | -1.14 | -0.12 | -0.24 |
| Non-Operating Income (Expense) | 0.00 | 0.09+28.6% | 0.07-91.8% | 0.85 | -0.18-178.3% | 0.23 | -0.73 | -0.35 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 49.61 | 49.04-12.7% | 56.19+6.4% | 52.80-18.2% | 64.56-47.1% | 122.00+5654.7% | 2.12+82.8% | 1.16 |
| Price To Earnings Ratio ratio statement ratio, not the snapshot | 57.60 | 57.60 | - | - | - | - | - | - |
| Price To Sales Ratio ratio | 0.34 | 0.99 | 0.79 | 0.88 | 1.49 | 2.07 | - | - |
| Operating Margin % | 0.88 | 0.37 | -3.76 | -7.01 | -8.97 | -15.25 | -0.55 | -3.90 |
| Net Margin % | 0.59 | -0.02 | -4.74 | -8.12 | -10.43 | -16.72 | -2.39 | -5.91 |
| Shares Outstanding million shares | 209.15 | 204.15+6.5% | 191.78+1.5% | 188.95+0.9% | 187.28+0.0% | 187.190.0% | 187.270.0% | 187.27 |
| Market Capitalization | 1,569.51 | 1,569.51-27.2% | 2,156.58+32.5% | 1,628.15-26.1% | 2,202.19-16.4% | 2,632.75+0.1% | 2,630.88 | - |
| Operating Income after Interest Expense | - | -1.05 | -125.10 | -149.05 | -146.93 | -195.51 | -22.19 | -44.38 |
| Reserves Increase (Decrease) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income statement, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,358.29+36.7% | 1,335.63+31.6% | 1,235.20+33.3% | 1,012.80+44.4% | 993.70+43.5% | 1,015.29+49.0% | 926.93+47.5% | 701.24+50.7% |
| Losses, Claims & Reserves | 1,217.60+40.3% | 1,154.68+31.0% | 1,090.72+32.9% | 889.49+44.7% | 868.02+41.5% | 881.74+45.7% | 820.90+43.2% | 614.90+47.2% |
| Selling, General and Administrative Incl. Other | 144.48+22.5% | 138.86+25.3% | 128.98+15.8% | 133.59+22.7% | 117.99+19.8% | 110.80+17.4% | 111.42+15.5% | 108.89+21.6% |
| Operating Income before Interest Expense | -3.79-149.3% | 42.10+85.1% | 15.50 | -10.28 | 7.68 | 22.75 | -5.39 | -22.55 |
| Interest Expense | 4.28+8.4% | 4.28+8.4% | 4.06+2.8% | 3.95-28.1% | 3.95-43.1% | 3.95-30.6% | 3.95-27.3% | 5.49+0.2% |
| Operating Income after Interest Expense | -8.07-316.4% | 37.83+101.2% | 11.44 | -14.23 | 3.73 | 18.80 | -9.34 | -28.04 |
| Unusual Expense | - | - | - | 0.00-100.0% | - | - | - | 3.02 |
| Net Income Before Taxes | -8.07-316.4% | 37.83+100.4% | 11.44 | -14.23 | 3.73 | 18.88 | -9.33 | -31.06 |
| Income Taxes | -0.02 | 1.27-60.6% | 0.03+50.0% | -3.23-32400.0% | 0.00 | 3.22+16000.0% | 0.02 | 0.01 |
| Consolidated Net Income | -8.05-315.8% | 36.56+133.6% | 11.42 | -11.01 | 3.73 | 15.65 | -9.35 | -31.06 |
| Net Income From Continuing Operations | -8.05-315.8% | 36.56+133.3% | 11.42 | -11.01 | 3.73 | 15.67 | -9.11 | -31.09 |
| Net Income | -8.05-315.8% | 36.56+133.3% | 11.42 | -11.01 | 3.73 | 15.67 | -9.11 | -31.09 |
| EPS (Recurring) per share | -0.04-300.0% | 0.17+142.9% | 0.05 | -0.05 | 0.02 | 0.07 | -0.05 | -0.15 |
| EPS (Basic, Before Extraordinaries) per share | -0.04-300.0% | 0.18+125.0% | 0.06 | -0.05 | 0.02 | 0.08 | -0.05 | -0.16 |
| EPS (Diluted) per share | -0.04-300.0% | 0.17+142.9% | 0.05 | -0.05 | 0.02 | 0.07 | -0.05 | -0.16 |
| Non-Operating Income (Expense) | 0.00 | 0.00-100.0% | 0.00-100.0% | 0.00 | 0.00-100.0% | 0.08-11.1% | 0.01 | 0.00-100.0% |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 13.81+7.7% | 14.36+16.8% | 11.08-18.4% | 10.36-19.3% | 12.82-5.9% | 12.29-7.3% | 13.58-17.5% | 12.83+3.7% |
| Price To Earnings Ratio ratio statement ratio, not the snapshot | 57.60 | 260.50 | - | - | - | - | - | - |
| Price To Sales Ratio ratio | 0.34 | 1.12 | 0.88 | 1.01 | 1.00 | 0.88 | 1.20 | 0.80 |
| Operating Margin % | -0.28 | 3.15 | 1.26 | -1.02 | 0.77 | 2.24 | -0.58 | -3.22 |
| Net Margin % | -0.59 | 2.74 | 0.92 | -1.09 | 0.38 | 1.54 | -0.98 | -4.43 |
| Shares Outstanding million shares | 209.15+4.6% | 207.18+4.7% | 206.67+4.6% | 204.15+6.5% | 199.99+4.4% | 197.96+3.5% | 197.67+3.4% | 191.78+1.5% |
| Market Capitalization | 1,569.51-54.6% | 4,922.34+77.7% | 3,599.71+0.8% | 3,951.82+83.2% | 3,455.64+52.8% | 2,769.80+85.2% | 3,571.91+281.1% | 2,156.58+32.5% |
Balance sheet, annual
| Metric | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 |
|---|---|---|---|---|---|---|---|
| Total Cash | 577.94+32.9% | 434.94+112.2% | 204.95-50.2% | 411.30-12.2% | 468.35+125.9% | 207.31+139.7% | 86.48 |
| Investments | 28.41-24.8% | 37.79-67.4% | 115.91 | 0.00 | 0.00 | 0.00 | 0.00 |
| Premium Balance Receivables - Insurance | 253.21+64.5% | 153.90+28.5% | 119.75+28.9% | 92.89+58.8% | 58.51+45.8% | 40.14+12.7% | 35.63 |
| Net Property, Plant & Equipment | 71.27-4.9% | 74.96+21.2% | 61.86+43.9% | 42.99+12.5% | 38.21+3.2% | 37.03+34.9% | 27.44 |
| Investment in Unconsolidated Affiliates | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Intangible Assets | 134.96+67.7% | 80.47-10.0% | 89.40+3.1% | 86.68+31.7% | 65.82+21.8% | 54.02+23.1% | 43.88 |
| Total Assets | 1,065.79+36.3% | 782.06+32.1% | 591.88-6.6% | 633.86+0.5% | 630.89+86.4% | 338.50+75.0% | 193.44 |
| Insurance Policy Liabilities - Insurance | 474.57+63.8% | 289.79+41.1% | 205.40+20.7% | 170.13+35.1% | 125.89+11.8% | 112.61+10.0% | 102.38 |
| Total Debt | 338.07-0.1% | 338.31+86.4% | 181.48+5.2% | 172.50+2.5% | 168.28+0.1% | 168.06+21.8% | 137.96 |
| Long Term Debt | 336.11-0.3% | 337.10+87.5% | 179.76+6.8% | 168.30+2.3% | 164.57-0.1% | 164.71+19.4% | 137.96 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 73.87+39.4% | 53.01+13.0% | 46.93-9.6% | 51.93+69.3% | 30.68+12.7% | 27.23-14.4% | 31.81 |
| Total Liabilities | 886.51+30.2% | 681.11+57.0% | 433.81+9.9% | 394.56+21.5% | 324.84+5.5% | 307.89+13.1% | 272.15 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 179.28+79.5% | 99.85-36.4% | 156.95-34.1% | 238.13-22.2% | 306.04+899.8% | 30.61 | -78.71 |
| Total Shareholders Equity | 179.28+79.5% | 99.85-36.4% | 156.95-34.1% | 238.13-22.2% | 306.04+899.8% | 30.61 | -78.71 |
| Accumulated Minority Interest | 0.00-100.0% | 1.10-1.8% | 1.12-5.1% | 1.18+11700.0% | 0.01 | 0.00 | 0.00 |
| Total Equity | 179.28+77.6% | 100.95-36.1% | 158.07-33.9% | 239.30-21.8% | 306.06+899.9% | 30.61 | -78.71 |
| Total Liabilities & Stockholders Equity | 1,065.79+36.3% | 782.06+32.1% | 591.88-6.6% | 633.86+0.5% | 630.89+86.4% | 338.50+75.0% | 193.44 |
| Book Value Per Share per share | 0.88+69.2% | 0.52-37.3% | 0.83-34.6% | 1.27-22.1% | 1.63+918.8% | 0.16 | -0.42 |
| Tangible Book Value Per Share per share | 0.70+118.8% | 0.32-48.4% | 0.62-41.5% | 1.06-26.9% | 1.45 | -0.02 | -0.61 |
| Full-Time Employees people | 1,849+10.1% | 1,679+9.3% | 1,536+48.1% | 1,037+22.4% | 847+9.3% | 775 | - |
| Price to Book Ratio ratio | 5.66 | 18.82 | 8.63 | 8.09 | 8.60 | 8.09 | - |
| Return on Assets % | -0.08 | -18.64 | -24.15 | -23.65 | -40.29 | -8.62 | - |
| Return on Equity % | -0.52 | -99.72 | -74.93 | -54.96 | -116.02 | - | - |
| Return on Invested Capital % | -0.14 | -29.30 | -43.96 | -36.80 | -41.50 | -11.74 | -75.50 |
| Current Ratio ratio | 1.71 | 1.88 | 1.84 | 2.37 | 3.31 | 1.72 | 0.98 |
Cash flow, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 |
|---|---|---|---|---|---|---|---|---|
| Funds from Operations | 127.73 | 94.42 | -26.12 | -61.21 | -39.87 | -59.36-1477.3% | 4.31 | -19.79 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -19.71 | 45.51-25.3% | 60.89+2899.5% | 2.03 | -5.55 | -19.42-697.5% | 3.25-88.8% | 29.00 |
| Cash from Operating Activities | 108.02 | 139.93+302.4% | 34.77 | -59.19 | -45.43 | -78.78-1142.1% | 7.56-17.9% | 9.21 |
| Capital Expenditures | -30.98 | -26.78 | -41.42 | -35.99 | -23.77 | -18.36 | -15.71 | -10.24 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | -4.14 | -1.41 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 1.14+3700.0% | 0.03-70.0% | 0.10+42.9% | 0.07+600.0% | 0.01-90.0% | 0.10 | 0.00 |
| Purchase or Sale of Investments | 11.49 | 10.67-86.8% | 80.59 | -111.27 | -0.40 | -1.05 | -0.75-7600.0% | 0.01 |
| Purchase of Investments | -52.95 | -65.63 | -82.20 | -379.06 | -2.83 | -2.48 | -1.57 | -0.32 |
| Sale Or Maturity of Investments | 64.44 | 76.30-53.1% | 162.79-39.2% | 267.79+10965.7% | 2.42+69.2% | 1.43+74.4% | 0.82+148.5% | 0.33 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -19.49 | -14.97-138.2% | 39.21 | -147.16 | -28.25 | -20.80 | -16.36 | -10.24 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 23.53 | 18.07 | 0.00 | 0.00 | 0.00-100.0% | 360.12+176.8% | 130.12 | -1.48 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.47 | -4.88 | -1.98 |
| Sale of Common Pref Stock | 23.53 | 18.07 | 0.00 | 0.00 | 0.00-100.0% | 361.59+167.8% | 135.00+26900.0% | 0.50 |
| Proceedsfrom Stock Options | 5.46 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 361.59+167.8% | 135.00+26900.0% | 0.50 |
| Issuance or Reduction of Debt, Net | 0.00 | 0.00-100.0% | 156.21 | 0.00-100.0% | 16.62 | 0.00 | 0.00-100.0% | 54.15 |
| Change in Long Term Debt | 0.00 | 0.00-100.0% | 156.21 | 0.00-100.0% | 16.62 | 0.00 | 0.00-100.0% | 54.15 |
| Issuance of Long Term Debt | 0.00 | 0.00-100.0% | 371.21 | 0.00-100.0% | 159.80 | 0.00 | 0.00-100.0% | 54.15 |
| Reduction of Long Term Debt | 0.00 | 0.00 | -215.00 | 0.00 | -143.18 | 0.00 | 0.00 | 0.00 |
| Net Financing Active Other Cash Flow | 0.00 | 0.00 | -0.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Activities Uses | -2.40 | -0.03 | -0.20 | 0.00 | -5.20 | 0.00 | 0.00 | -0.85 |
| Cash from Financing Activities | 21.13 | 18.04-88.4% | 156.01 | 0.00-100.0% | 16.62-95.4% | 360.12+176.8% | 130.12+147.1% | 52.66 |
| Net Change in Cash | 109.66 | 142.99-37.8% | 229.99 | -206.34 | -57.05-121.9% | 260.54+114.7% | 121.33+135.0% | 51.63 |
| Free Cash Flow | 77.04 | 113.15 | -6.65 | -95.18 | -69.20 | -97.14 | -8.15 | -1.04 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price to Free Cash Flow ratio | 22.09 | 34.56 | - | - | - | - | - | - |
Balance sheet, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Total Cash | 729.84+17.7% | 695.59+47.3% | 1,411.17+58.1% | 577.94+32.9% | 620.18+81.0% | 472.36+38.5% | 892.37+270.1% | 434.94+112.2% |
| Investments | 16.29-37.4% | 8.26-75.4% | 20.71-37.9% | 28.41-24.8% | 26.01-36.1% | 33.51+35.7% | 33.36-46.9% | 37.79-67.4% |
| Net Property, Plant & Equipment | 73.64-1.0% | 73.52-4.6% | 70.94-7.0% | 71.27-4.9% | 74.36+2.1% | 77.10+9.3% | 76.25+16.0% | 74.96+21.2% |
| Investment in Unconsolidated Affiliates | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Intangible Assets | 234.54+44.6% | 204.78+52.5% | -518.88 | 134.96+67.7% | 162.23+66.8% | 134.25+38.7% | -320.42-425.3% | 80.47-10.0% |
| Total Assets | 1,296.86+17.6% | 1,279.04+27.9% | 1,261.61+40.9% | 1,065.79+36.3% | 1,102.61+59.3% | 1,000.15+39.6% | 895.62+41.4% | 782.06+32.1% |
| Insurance Policy Liabilities - Insurance | 621.75+17.6% | 612.75+34.6% | 655.97+65.3% | 474.57+63.8% | 528.80+78.0% | 455.15+44.3% | 396.73+43.5% | 289.79+41.1% |
| Total Debt | 330.70+0.3% | 330.50+0.3% | 329.97+0.1% | 338.07-0.1% | 329.66+49.7% | 329.66+49.9% | 329.50+93.3% | 338.31+86.4% |
| Long Term Debt | 330.70+0.3% | 330.50+0.3% | 329.97+0.1% | 336.11-0.3% | 329.66+50.8% | 329.66+49.9% | 329.50+93.3% | 337.10+87.5% |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 67.31-18.2% | 70.66-5.0% | 68.79+13.9% | 73.87+39.4% | 82.29+38.7% | 74.37+32.4% | 60.38+11.2% | 53.01+13.0% |
| Total Liabilities | 1,019.75+8.4% | 1,013.91+18.0% | 1,054.72+34.1% | 886.51+30.2% | 940.74+63.1% | 859.18+45.3% | 786.62+56.9% | 681.11+57.0% |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 277.11+71.2% | 265.13+88.1% | 206.88+91.3% | 179.28+79.5% | 161.87+41.3% | 140.97+14.0% | 108.13-17.4% | 99.85-36.4% |
| Total Shareholders Equity | 277.11+71.2% | 265.13+88.1% | 206.88+91.3% | 179.28+79.5% | 161.87+41.3% | 140.97+14.0% | 108.13-17.4% | 99.85-36.4% |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% | 0.86-21.1% | 1.10-1.8% |
| Total Equity | 277.11+71.2% | 265.13+88.1% | 206.88+89.8% | 179.28+77.6% | 161.87+40.0% | 140.97+13.0% | 109.00-17.4% | 100.95-36.1% |
| Total Liabilities & Stockholders Equity | 1,296.86+17.6% | 1,279.04+27.9% | 1,261.61+40.9% | 1,065.79+36.3% | 1,102.61+59.3% | 1,000.15+39.6% | 895.62+41.4% | 782.06+32.1% |
| Book Value Per Share per share | 1.32+63.0% | 1.28+80.3% | 1.00+81.8% | 0.88+69.2% | 0.81+35.0% | 0.71+9.2% | 0.55-19.1% | 0.52-37.3% |
| Tangible Book Value Per Share per share | 1.15+82.5% | 1.10+107.5% | 0.82+134.3% | 0.70+118.8% | 0.63+61.5% | 0.53+20.5% | 0.35-27.1% | 0.32-48.4% |
| Full-Time Employees people | - | - | - | 1,849+10.1% | - | - | - | 1,679+9.3% |
| Price to Book Ratio ratio | 5.66 | 23.79 | 20.06 | 24.40 | 24.50 | 25.59 | 35.76 | 18.82 |
| Return on Assets % | 2.41 | 3.57 | 1.84 | -0.08 | -2.32 | -5.94 | -11.86 | -18.64 |
| Return on Equity % | 13.17 | 20.04 | 12.57 | -0.52 | -15.06 | -38.50 | -75.82 | -99.72 |
| Return on Invested Capital % | -1.32 | 6.14 | 2.13 | -2.14 | 0.76 | 3.33 | -2.08 | -7.12 |
| Current Ratio ratio | 1.71 | 1.70 | 1.58 | 1.71 | 1.61 | 1.66 | 1.69 | 1.88 |
Cash flow, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Funds from Operations | 19.01-35.1% | 63.87+66.5% | 34.01+113.5% | 10.84 | 29.29 | 38.36 | 15.93 | -4.77 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | 28.02-75.7% | -81.18 | 94.67+13620.3% | -61.22 | 115.27+323.9% | -9.23-138.2% | 0.69-94.9% | -3.94 |
| Cash from Operating Activities | 47.03-67.5% | -17.31-159.4% | 128.68+674.2% | -50.38 | 144.56+452.0% | 29.13+23.8% | 16.62 | -8.71 |
| Capital Expenditures | -8.44 | -10.14 | -7.36 | -5.03 | -5.50 | -8.00 | -8.25 | -9.28 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00-100.0% | 0.00 | 0.00 | 0.00-100.0% | 1.14 | 0.00-100.0% | 0.00-100.0% |
| Purchase or Sale of Investments | -6.88-188.1% | 12.56+6180.0% | 7.94+65.8% | -2.13-163.4% | 7.81 | 0.20-99.5% | 4.79-91.1% | 3.36-64.9% |
| Purchase of Investments | -15.68 | -6.24 | -10.60 | -20.44 | -10.19 | -17.10 | -17.91 | -6.68 |
| Sale Or Maturity of Investments | 8.79-51.2% | 18.80+8.7% | 18.54-18.3% | 18.30+82.3% | 18.00-11.0% | 17.30-69.7% | 22.70-69.9% | 10.04-90.6% |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -15.32-763.2% | 2.42 | 0.58 | -7.16 | 2.31 | -6.66-124.7% | -3.46-108.1% | -5.92 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 2.55+168.4% | 3.51+116.7% | 2.17+933.3% | 15.30 | 0.95 | 1.62 | 0.21 | 0.00 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 2.55+168.4% | 3.51+116.7% | 2.17+933.3% | 15.30 | 0.95 | 1.62 | 0.21 | 0.00 |
| Proceedsfrom Stock Options | 2.55+168.4% | 3.51+116.7% | 2.17+933.3% | -2.77 | 0.95 | 1.62 | 0.21 | 0.00 |
| Issuance or Reduction of Debt, Net | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.00 | 0.00-100.0% | 0.00 | 106.72 |
| Change in Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.00 | 0.00-100.0% | 0.00 | 106.72 |
| Issuance of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.00 | 0.00-100.0% | 0.00 | 321.72 |
| Reduction of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -215.00 |
| Net Financing Active Other Cash Flow | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.00 | 0.00 | 0.00 | 0.15 |
| Other Financing Activities Uses | 0.00 | -0.74 | -1.66 | 0.00-100.0% | 0.00 | 0.00 | -0.03 | 0.15 |
| Cash from Financing Activities | 2.55+168.4% | 2.77+71.0% | 0.52+188.9% | 15.30-85.7% | 0.95 | 1.62-96.7% | 0.18 | 106.88 |
| Net Change in Cash | 34.25-76.8% | -12.12-150.3% | 129.78+872.9% | -42.24-145.8% | 147.82+8968.7% | 24.08-75.9% | 13.34-63.1% | 92.24 |
| Free Cash Flow | 38.58-72.3% | -27.46-230.0% | 121.32+1351.2% | -55.40 | 139.06+722.4% | 21.13+79.1% | 8.36 | -18.00 |
| Price to Free Cash Flow ratio | 22.09 | 28.84 | 16.61 | 35.08 | 24.22 | 103.26 | 188.99 | - |
Revenue breakdown
USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| Total Hospital & Medical Service Plans revenue | 2,703.56 | 3,948.72 | +46.1% | 100.0% |
| Total | 2,703.56 | 3,948.72 | +46.1% | 100.0% |
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| United States | 2,703.56 | 3,948.72 | +46.1% | 100.0% |
| Total | 2,703.56 | 3,948.72 | +46.1% | 100.0% |
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 11.57% | 23.1M | 200.1M | 8.53M |
| 2026-10-15 | 12.86% | 25.5M | 198.4M | 8.15M |
| 2026-09-30 | 11.90% | 23.6M | 198.4M | 7.13M |
| 2026-09-15 | 12.41% | 24.6M | 198.3M | 5.48M |
| 2026-08-31 | 11.56% | 22.8M | 197.6M | 5.70M |
| 2026-08-14 | 11.91% | 23.5M | 197.6M | 5.71M |
| 2026-07-31 | 11.22% | 22.0M | 196.5M | 6.20M |
| 2026-07-15 | 12.67% | 24.8M | 195.9M | 5.95M |
| 2026-06-30 | 12.46% | 24.4M | 195.6M | 5.67M |
| 2026-06-15 | 13.01% | 25.4M | 195.4M | 5.29M |
| 2026-05-29 | 13.03% | 25.4M | 195.2M | 4.49M |
| 2026-05-15 | 12.85% | 25.1M | 195.2M | 4.36M |
| 2026-04-30 | 8.86% | 16.1M | 182.0M | 3.13M |
| 2026-04-15 | 9.43% | 17.0M | 179.8M | 3.14M |
| 2026-03-31 | 9.18% | 16.4M | 178.3M | 2.97M |
| 2026-03-13 | 8.92% | 15.9M | 178.3M | 2.91M |
| 2026-02-27 | 8.93% | 15.9M | 178.3M | 2.73M |
| 2026-02-13 | 9.19% | 16.1M | 174.6M | 2.75M |
| 2026-01-30 | 9.31% | 16.2M | 174.2M | 2.81M |
| 2026-01-15 | 9.93% | 17.3M | 174.2M | 2.59M |
Option chain
Expiry 2026-11-20 · underlying 7.45, quoted 13 Nov 07:01 ET · ATM 7.50
Option quotes 12 Nov 15:05 ET. A date on a row is older than the last session (12 Nov). 36 rows.
Implied move 8.05% into expiry (call 0.300 + put 0.300 = 0.600 on 7.45)
Put/call open interest 0.04 (1,515 puts / 36,282 calls) · Put/call volume 2.00 (4 puts / 2 calls)
IV change is points against the prior close.
| Type | Strike | Money | Bid | Ask | Last | Chg | IV | Open int | Volume | Last size | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| call 1 Jan | 1.00 | ITM | 6.00 | 7.50 | 0.00 | 0.00 | - | 0 | 0 | 0 | 0.989 | -0.016 | 0.000 |
| put 1 Jan | OTM | 0.00 | 0.05 | 0.00 | 0.00 | - | 0 | 0 | 0 | -0.010 | -0.014 | 0.000 | |
| call 17 Aug | 2.50 | ITM | 4.60 | 5.80 | 11.00 | 0.00 | 1058.0% +277.9 | 1 | 0 | 0 | 0.937 | -0.068 | 0.001 |
| put 1 Jan | OTM | 0.00 | 0.75 | 0.00 | 0.00 | 780.1% 0.0 | 0 | 0 | 0 | -0.063 | -0.067 | 0.001 | |
| call 1 Jan | 4.00 | ITM | 3.10 | 4.30 | 0.00 | 0.00 | 671.5% +179.5 | 0 | 0 | 0 | 0.891 | -0.065 | 0.002 |
| put 1 Jan | OTM | 0.00 | 0.75 | 0.00 | 0.00 | 492.0% 0.0 | 0 | 0 | 0 | -0.109 | -0.064 | 0.002 | |
| call 10 Nov | 5.00 | ITM | 2.10 | 3.30 | 2.68 | 0.00 | 503.6% +143.8 | 23 | 0 | 0 | 0.850 | -0.059 | 0.003 |
| put 19 Oct | OTM | 0.00 | 0.75 | 0.01 | 0.00 | 359.8% 0.0 | 134 | 0 | 0 | -0.150 | -0.059 | 0.003 | |
| call 1 Jan | 6.00 | ITM | 1.20 | 2.15 | 0.00 | 0.00 | 323.0% +73.8 | 0 | 0 | 0 | 0.787 | -0.051 | 0.003 |
| put 5 Nov | OTM | 0.00 | 0.40 | 0.05 | 0.00 | 249.1% 0.0 | 50 | 0 | 0 | -0.213 | -0.051 | 0.003 | |
| call 11 Nov | 7.50 | ATM | 0.20 | 0.40 | 0.40 | 0.00 | 90.6% -0.8 | 884 | 0 | 0 | 0.529 | -0.026 | 0.004 |
| put 11 Nov | ATM | 0.20 | 0.40 | 0.32 | 0.00 | 92.1% +0.7 | 878 | 0 | 0 | -0.471 | -0.025 | 0.004 | |
| call 6 Nov | 9.00 | OTM | 0.00 | 0.05 | 0.14 | 0.00 | 261.3% 0.0 | 374 | 0 | 0 | 0.422 | -0.073 | 0.004 |
| put 4 Nov | ITM | 0.95 | 1.85 | 0.99 | 0.00 | 191.5% +97.2 | 10 | 0 | 0 | -0.893 | -0.011 | 0.002 | |
| call | 10.00 | OTM | 0.00 | 0.10 | 0.05 | 0.00 | 131.5% 0.0 | 13,929 | 2 | 2 | 0.082 | -0.014 | 0.002 |
| put | ITM | 1.70 | 2.85 | 2.42 | +0.22 | 241.7% +110.2 | 148 | 4 | 4 | -0.918 | -0.013 | 0.002 | |
| call 4 Nov | 11.00 | OTM | 0.00 | 0.55 | 0.05 | 0.00 | 162.9% 0.0 | 14 | 0 | 0 | 0.069 | -0.015 | 0.001 |
| put 11 Nov | ITM | 3.10 | 4.10 | 3.29 | 0.00 | 351.4% +188.5 | 0 | 0 | 0 | -0.931 | -0.014 | 0.001 | |
| call 30 Oct | 12.50 | OTM | 0.00 | 0.25 | 0.04 | 0.00 | 202.7% 0.0 | 6,173 | 0 | 0 | 0.058 | -0.017 | 0.001 |
| put 11 Nov | ITM | 4.20 | 5.40 | 4.74 | 0.00 | 350.5% +147.8 | 81 | 0 | 0 | -0.942 | -0.015 | 0.001 | |
| call 1 Jan | 14.00 | OTM | 0.00 | 0.95 | 0.00 | 0.00 | 236.3% 0.0 | 0 | 0 | 0 | 0.052 | -0.018 | 0.001 |
| put 1 Jan | ITM | 5.50 | 7.10 | 0.00 | 0.00 | 452.5% +216.2 | 0 | 0 | 0 | -0.948 | -0.016 | 0.001 | |
| call 30 Oct | 15.00 | OTM | 0.00 | 0.75 | 0.01 | 0.00 | 256.1% 0.0 | 4,284 | 0 | 0 | 0.049 | -0.018 | 0.001 |
| put 6 Oct | ITM | 6.60 | 8.00 | 6.50 | 0.00 | 450.7% +194.6 | 50 | 0 | 0 | -0.951 | -0.017 | 0.001 | |
| call 1 Jan | 16.00 | OTM | 0.00 | 0.80 | 0.00 | 0.00 | 274.3% 0.0 | 0 | 0 | 0 | 0.046 | -0.019 | 0.001 |
| put 1 Jan | ITM | 7.60 | 9.00 | 0.00 | 0.00 | 474.5% +200.3 | 0 | 0 | 0 | -0.954 | -0.017 | 0.001 | |
| call 29 Sep | 17.50 | OTM | 0.00 | 0.75 | 0.36 | 0.00 | 299.0% 0.0 | 3,663 | 0 | 0 | 0.043 | -0.019 | 0.001 |
| put 5 Nov | ITM | 9.00 | 10.50 | 9.40 | 0.00 | 507.0% +208.0 | 114 | 0 | 0 | -0.957 | -0.017 | 0.001 | |
| call 6 Nov | 20.00 | OTM | 0.00 | 0.05 | 0.05 | 0.00 | 308.3% 0.0 | 5,415 | 0 | 0 | 0.040 | -0.018 | 0.001 |
| put 14 Jul | ITM | 11.30 | 13.30 | 3.00 | 0.00 | 640.1% +305.3 | 50 | 0 | 0 | -0.960 | -0.018 | 0.001 | |
| call 29 Sep | 22.50 | OTM | 0.00 | 0.05 | 0.40 | 0.00 | 337.3% 0.0 | 1,452 | 0 | 0 | 0.037 | -0.019 | 0.001 |
| put 29 Apr | ITM | 13.60 | 16.00 | 3.65 | 0.00 | 733.7% +368.5 | 0 | 0 | 0 | -0.963 | -0.018 | 0.001 | |
| call 14 Aug | 25.00 | OTM | 0.00 | 0.05 | 0.60 | 0.00 | 362.6% 0.0 | 28 | 0 | 0 | 0.035 | -0.019 | 0.001 |
| put 19 Aug | ITM | 16.10 | 18.50 | 11.90 | 0.00 | 769.9% +377.9 | 0 | 0 | 0 | -0.965 | -0.019 | 0.001 | |
| call 24 Jul | 30.00 | OTM | 0.00 | 0.05 | 0.80 | 0.00 | 405.2% 0.0 | 31 | 0 | 0 | 0.032 | -0.020 | 0.001 |
| put 1 Jan | ITM | 21.20 | 23.60 | 0.00 | 0.00 | 856.1% +419.1 | 0 | 0 | 0 | -0.967 | -0.019 | 0.001 | |
| call 21 Sep | 35.00 | OTM | 0.00 | 0.05 | 0.05 | 0.00 | 440.2% 0.0 | 11 | 0 | 0 | 0.030 | -0.021 | 0.001 |
| put 1 Jan | ITM | 26.20 | 28.90 | 0.00 | 0.00 | 980.4% +506.4 | 0 | 0 | 0 | -0.969 | -0.019 | 0.001 |
Latest SEC filings
30 of 817AllAll annual, quarterly, and current reportsInsider equity awards, transactions, and ownership (Section 16 Reports)Beneficial ownership reportsExempt offeringsRegistration statements and prospectusesFiling review correspondenceSEC orders and noticesProxy materialsTender offers and going private transactionsTrust indenture filings
10-Q filed 2026-10-29, period ended 2026-09-30. 10-K filed 2026-02-27, period ended 2025-12-31. ALHC on EDGAR
page 1 of 28Next →
| Filed | Form | Description | Period | Document |
|---|---|---|---|---|
| 2026-11-12 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-11-10 · transaction | 0001628280-26-073517 index |
| 2026-11-10 | SCHEDULE 13G/A | Beneficial ownership reports | no report period | 0000914208-26-000384 index |
| 2026-11-09 | 144 | no category | no report period | 0001628280-26-072366 index |
| 2026-11-05 | SCHEDULE 13G/A | Beneficial ownership reports | no report period | 0000315066-26-002673 index |
| 2026-10-29 | 10-Q | All annual, quarterly, and current reports | 2026-09-30 | 0001628280-26-068247 index |
| 2026-10-29 | 8-K | All annual, quarterly, and current reports | 2026-10-29 | 0001171843-26-006971 index |
| 2026-10-08 | 8-K | All annual, quarterly, and current reports | 2026-10-08 | 0001628280-26-065470 index |
| 2026-10-07 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-10-06 · transaction | 0001628280-26-065321 index |
| 2026-10-05 | SCHEDULE 13G/A | Beneficial ownership reports | no report period | 0002012383-26-003312 index |
| 2026-10-05 | 144 | no category | no report period | 0001628280-26-065053 index |
| 2026-09-18 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-09-17 · transaction | 0001628280-26-062740 index |
| 2026-09-16 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-09-14 · transaction | 0001628280-26-062329 index |
| 2026-09-16 | 144 | no category | no report period | 0001628280-26-062327 index |
| 2026-09-11 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-09-11 · transaction | 0001628280-26-061621 index |
| 2026-09-11 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-09-10 · transaction | 0001628280-26-061620 index |
| 2026-09-10 | 144 | no category | no report period | 0001950047-26-009291 index |
| 2026-09-09 | 144 | no category | no report period | 0001628280-26-061187 index |
| 2026-09-09 | 144 | no category | no report period | 0001628280-26-061184 index |
| 2026-08-18 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-08-14 · transaction | 0001628280-26-057635 index |
| 2026-08-14 | 144 | no category | no report period | 0001950047-26-008148 index |
| 2026-08-13 | SCHEDULE 13G | Beneficial ownership reports | no report period | 0000914208-26-000265 index |
| 2026-08-10 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-08-10 · transaction | 0001628280-26-055418 index |
| 2026-07-31 | SCHEDULE 13G | Beneficial ownership reports | no report period | 0002100121-26-000929 index |
| 2026-07-30 | 10-Q | All annual, quarterly, and current reports | 2026-06-30 | 0001628280-26-051060 index |
| 2026-07-30 | 8-K | All annual, quarterly, and current reports | 2026-07-30 | 0001171843-26-005078 index |
| 2026-07-27 | SCHEDULE 13G/A | Beneficial ownership reports | no report period | 0002012383-26-002167 index |
| 2026-07-16 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-07-15 · transaction | 0001628280-26-048498 index |
| 2026-07-15 | 144 | no category | no report period | 0001950047-26-007102 index |
| 2026-07-14 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-07-10 · transaction | 0001628280-26-048170 index |
| 2026-07-10 | 144 | no category | no report period | 0001950047-26-007006 index |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 35.50K | 1 |
| 2026-10 | 0 | 0 | 269.58K | 1 |
| 2026-09 | 0 | 0 | 9.24M | 5 |
| 2026-08 | 0 | 0 | 4.21M | 2 |
| 2026-07 | 0 | 0 | 10.21M | 3 |
| 2026-06 | 197.63K | 1 | 9.02M | 6 |
| 2026-05 | 0 | 0 | 5.52M | 2 |
| 2026-04 | 0 | 0 | 12.60M | 6 |
| 2026-03 | 0 | 0 | 11.32M | 15 |
| 2026-02 | 0 | 0 | 4.76M | 3 |
| 2026-01 | 0 | 0 | 11.91M | 6 |
| 2025-12 | 0 | 0 | 438.11M | 12 |
| 2025-11 | 0 | 0 | 3.49M | 3 |
Institutional holders
| Manager | % owned |
|---|---|
| BlackRock, Inc. | 9.36% |
| WELLINGTON MANAGEMENT GROUP LLP | 9.08% |
| T. Rowe Price Investment Management, Inc. | 6.35% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.65% |
| BANK OF AMERICA CORP /DE/ | 4.52% |
| FMR LLC | 4.19% |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.94% |
| STATE STREET CORP | 3.81% |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 3.01% |
| Hood River Capital Management LLC | 2.99% |
Funds
| Fund | % owned |
|---|---|
| SMALLCAP World Fund Inc | 3.58% |
| VANGUARD HEALTH CARE FUND | 3.35% |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | 2.85% |
| iShares Russell 2000 ETF | 2.22% |
| VANGUARD SMALL-CAP INDEX FUND | 2.06% |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 2.01% |
| Hood River Small-Cap Growth Fund | 1.97% |
| VANGUARD SMALL-CAP GROWTH INDEX FUND | 1.19% |
| Virtus Convertible & Income Fund | 1.13% |
| T. Rowe Price Institutional Small-Cap Stock Fund | 1.10% |
OakChart. ALHC. Cached 15 minutes. Terms